Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9tx00149b

Novel experimental anticancer gold-based compounds were studied for their mechanisms of toxicity in healthy rat kidney and liver tissues, using the Precision Cut Tissue Slices (PCTS) technique. Gold-based compounds are of great interest in the field of medicinal chemistry as novel therapeutic (antic...

Full description

Saved in:
Bibliographic Details
Published inToxicology research (Cambridge) Vol. 8; no. 6; pp. 885 - 895
Main Authors Estrada-Ortiz, Natalia, Lopez-Gonzales, Elena, Woods, Ben, Stürup, Stefan, de Graaf, Inge A. M., Groothuis, Geny M. M., Casini, Angela
Format Journal Article
LanguageEnglish
Published Royal Society of Chemistry 20.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Novel experimental anticancer gold-based compounds were studied for their mechanisms of toxicity in healthy rat kidney and liver tissues, using the Precision Cut Tissue Slices (PCTS) technique. Gold-based compounds are of great interest in the field of medicinal chemistry as novel therapeutic (anticancer) agents due to their peculiar reactivity and mechanisms of action with respect to organic drugs. Despite their promising pharmacological properties, the possible toxic effects of gold compounds need to be carefully evaluated in order to optimize their design and applicability. This study reports on the potential toxicity of three experimental gold-based anticancer compounds featuring lansoprazole ligands ( 1–3 ) studied in an ex vivo model, using rat precision cut kidney and liver slices (PCKS and PCLS, respectively). The results showed a different toxicity profile for the tested compounds, with the neutral complex 2 being the least toxic, even less toxic than cisplatin, followed by the cationic complex 1 . The dinuclear cationic gold complex 3 was the most toxic in both liver and kidney slices. This result correlated with the metal uptake of the different compounds assessed by ICP-MS, where complex 3 showed the highest accumulation of gold in liver and kidney slices. Interestingly compound 1 showed the highest selectivity towards cancer cells compared to the healthy tissues. Histomorphology evaluation showed a similar pattern for all three Au( i ) complexes, where the distal tubular cells suffered the most extensive damage, in contrast to the damage in the proximal tubules induced by cisplatin. The binding of representative gold compounds with the model ubiquitin was also studied by ESI-MS, showing that after 24 h incubation only ‘naked’ Au ions were bound to the protein following ligands’ loss. The mRNA expression of stress response genes appeared to be similar for both evaluated organs, suggesting oxidative stress as the possible mechanism of toxicity. The obtained results open new perspectives towards the design and testing of bifunctional gold complexes with chemotherapeutic applications.
AbstractList Novel experimental anticancer gold-based compounds were studied for their mechanisms of toxicity in healthy rat kidney and liver tissues, using the Precision Cut Tissue Slices (PCTS) technique. Gold-based compounds are of great interest in the field of medicinal chemistry as novel therapeutic (anticancer) agents due to their peculiar reactivity and mechanisms of action with respect to organic drugs. Despite their promising pharmacological properties, the possible toxic effects of gold compounds need to be carefully evaluated in order to optimize their design and applicability. This study reports on the potential toxicity of three experimental gold-based anticancer compounds featuring lansoprazole ligands ( 1–3 ) studied in an ex vivo model, using rat precision cut kidney and liver slices (PCKS and PCLS, respectively). The results showed a different toxicity profile for the tested compounds, with the neutral complex 2 being the least toxic, even less toxic than cisplatin, followed by the cationic complex 1 . The dinuclear cationic gold complex 3 was the most toxic in both liver and kidney slices. This result correlated with the metal uptake of the different compounds assessed by ICP-MS, where complex 3 showed the highest accumulation of gold in liver and kidney slices. Interestingly compound 1 showed the highest selectivity towards cancer cells compared to the healthy tissues. Histomorphology evaluation showed a similar pattern for all three Au( i ) complexes, where the distal tubular cells suffered the most extensive damage, in contrast to the damage in the proximal tubules induced by cisplatin. The binding of representative gold compounds with the model ubiquitin was also studied by ESI-MS, showing that after 24 h incubation only ‘naked’ Au ions were bound to the protein following ligands’ loss. The mRNA expression of stress response genes appeared to be similar for both evaluated organs, suggesting oxidative stress as the possible mechanism of toxicity. The obtained results open new perspectives towards the design and testing of bifunctional gold complexes with chemotherapeutic applications.
Author Estrada-Ortiz, Natalia
Lopez-Gonzales, Elena
Casini, Angela
Stürup, Stefan
Woods, Ben
de Graaf, Inge A. M.
Groothuis, Geny M. M.
AuthorAffiliation a Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: g.m.m.groothuis@rug.nl ; Email: angela.casini@tum.de
c Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark
b School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK
d Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
AuthorAffiliation_xml – name: d Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– name: c Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark
– name: a Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: g.m.m.groothuis@rug.nl ; Email: angela.casini@tum.de
– name: b School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK
Author_xml – sequence: 1
  givenname: Natalia
  surname: Estrada-Ortiz
  fullname: Estrada-Ortiz, Natalia
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 2
  givenname: Elena
  surname: Lopez-Gonzales
  fullname: Lopez-Gonzales, Elena
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 3
  givenname: Ben
  surname: Woods
  fullname: Woods, Ben
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 4
  givenname: Stefan
  surname: Stürup
  fullname: Stürup, Stefan
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 5
  givenname: Inge A. M.
  surname: de Graaf
  fullname: de Graaf, Inge A. M.
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 6
  givenname: Geny M. M.
  surname: Groothuis
  fullname: Groothuis, Geny M. M.
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
– sequence: 7
  givenname: Angela
  surname: Casini
  fullname: Casini, Angela
  organization: Dept. Pharmacokinetics , Toxicology and Targeting , Groningen Research Institute of Pharmacy , University of Groningen , A. Deusinglaan 1 , 9713AV Groningen , The Netherlands . Email: ; Email: School of Chemistry , Cardiff University , Main Building , Park Place , CF10 3AT Cardiff , UK Dept. of Pharmacy , University of Copenhagen , Universitetsparken 2 , 2100 Copenhagen , Denmark Department of Chemistry , Technical University of Munich , Lichtenbergstr. 4 , 85748 Garching b. München , Germany
BookMark eNqljz1OAzEQhS0URAKk4QRTJkWC9ycJS0FDFpGKIhR0K8eZbIy8HmvtLBsqjsJhOAknwQKEhCgZaTQjvZnv6R2zjiGDjJ1FfBzxJDuXmW85j9JsdcB6MU8no3SSXHR-9vihy_rOPfJQMx5Pk8kR6yZxlPE4S3rsLW-hUQ2Bp1ZJ0lQqKTRgI_ROeEUGaAPYWqxVhcYHSRgfTozEGkrS64EagqTKamzRwZPyW9DCOLK1eCaNI7-3CFqVwqzd-8srhM41Sl-TURLczobPT3K9B2U2VFdftoN8uRiCaITSYqVxDEtEmN8tLuFv8lN2uBHaYf97nrCrm_z--nZkd6sK1zLga6ELGzIEm4KEKn4rRm2LkppixqezOI2SfwM-AFvkiwc
ContentType Journal Article
Copyright This journal is © The Royal Society of Chemistry 2019 2019
Copyright_xml – notice: This journal is © The Royal Society of Chemistry 2019 2019
DBID 5PM
DOI 10.1039/c9tx00149b
DatabaseName PubMed Central (Full Participant titles)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Public Health
EISSN 2045-4538
EndPage 895
GroupedDBID -JG
0-7
0R~
4.4
53G
5PM
5WD
705
AABZA
AACZT
AAEMU
AAHBH
AAIWI
AAJAE
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAVAP
AAWGC
ABEMK
ABGFH
ABJNI
ABMNT
ABNHQ
ABPQP
ABPTD
ABWST
ABXOH
ABXVV
ACGFS
ACLDK
ACPRK
ACUFI
ADBBV
ADGKP
ADGZP
ADIPN
ADIYS
ADMRA
ADQBN
ADSRN
ADVEK
AEFDR
AELWJ
AENEX
AESAV
AETBJ
AFFZL
AFGWE
AFLYV
AFRAH
AFVBQ
AGINJ
AGQXC
AGSTE
AHGCF
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ANUXI
AOIJS
APEMP
ASKNT
ATGXG
AUDPV
BCRHZ
BEYMZ
BSQNT
C6K
EBS
EE0
EF-
EJD
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
H13
HH5
HYE
HZ~
H~N
J3I
KBUDW
KOP
KSI
KSN
ML0
NOMLY
O-G
O9-
OBOKY
OCZFY
OJZSN
OK1
OPAEJ
OWPYF
R7G
RCNCU
ROX
RPM
RPMJG
RRC
RSCEA
RUSNO
SKA
SLH
YXANX
ID FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_70672413
IEDL.DBID RPM
ISSN 2045-452X
IngestDate Tue Sep 17 21:12:35 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_70672413
PMID 32190293
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7067241
PublicationCentury 2000
PublicationDate 20190920
PublicationDateYYYYMMDD 2019-09-20
PublicationDate_xml – month: 9
  year: 2019
  text: 20190920
  day: 20
PublicationDecade 2010
PublicationTitle Toxicology research (Cambridge)
PublicationYear 2019
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
SSID ssj0000702635
Score 4.3372416
Snippet Novel experimental anticancer gold-based compounds were studied for their mechanisms of toxicity in healthy rat kidney and liver tissues, using the Precision...
SourceID pubmedcentral
SourceType Open Access Repository
StartPage 885
SubjectTerms Chemistry
Title Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9tx00149b
URI https://pubmed.ncbi.nlm.nih.gov/PMC7067241
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTsJAEJ4AByUxRlHjf-bgAQ6lQFtqPZgYLAET1ARNuJFud8EmpSWlkurJR_FhfBKfxN0tVYg3Dj01zTazuzPf7H7zDcCFdUmaAggoI56cKDppjhRi6FShHIwQovGIIav4e_fNzrN-NzAGOTCyWhhJ2neJVw38STXwXiS3cjpx1Ywnpj72Wqa4P9Trah7ypqYtpejS_Zo1IbAimspxuKLoRmOQyZJqlupacSLTAlKEDY1v11pD3DmvEiKXIkx7B7YX0BBv0l_YhRwLSrDZyjqylWArPWPDtHRoD77sBOfePMQ4TDw382L4J-CN4QiXJfyRm1G4PZdFOA59WvYqKDnlLGEzFEey6PPQFU4j5z30mSLOZ9H3xqIc-PvjE_lj_7bNwZloCJqSz6M3XCiwymHLdr9bQWfueL6ozKpinzG8fehe4X8D7cN1235qdZQV2wynqQrGUOhSr77h0yX1qRfTox1AIQgDdghoGjwWW3W-YEzKESCzGONAjFqUOHqdGvQIzDUHOV77yxMocvAj-WKN2ikU4uiVnXGAEZNzuaB-AHZU3rY
link.rule.ids 230,315,733,786,790,891,27957,27958,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTsJAEJ4gJkJi_EGN_87BAxxa_lpqPZgYhIACmoCGG2HbBRtLS6AQ5OSj-DA-iU_i7pYq6EkOPW2a3czuzny7-803AOf6BclxICB12OFEUkiuIxFVMSWTgRFCsixiiCz-ai1XelRum2ozBGqQCyNI-waxZMfuyY71LLiV_Z6RDHhiyYdqXuPvh0o6uQKrbL9mtLlDunDAWopLrPCycgywSIqaaQbCpFk9aejeRBwMSBTWsmzDpjL81XmREjkXY4qb8BSMzqeWvMgjj8jG9Jdw47-HvwUbM9SJ137zNoSoE4NIPij2FoN1__oO_aykHfgoTHBsjV303IllBA4Sf7TB0e3gfHUAZDPEPapBB9h1bTNuJVDQ1emEDpHf9qLNoqLbH7Snrk0lfvWLttXlmcafb-_IvsJ3RR4c8lqjPq998IozcVfRbbxQLyewPW5bNk_6krFOKd7cly_xr-V34apYaORL0oLRW31fYKPFJa8XW5gphfT1zHTZPQg7rkP3ATWVhXk9zdaiZjJwSXVKGcYzdZO0lbSpmgegLdnJ4dJ_nkGk1KhWWpVy7e4IogxjCVpaJnUMYW8woicMx3jkVKzaLwflALg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB1BkaASYkfszIEDHJJ0SRrCAQl1UcsuAVLFpYpjt0SkSZWmVemJT-Fj-BK-BNtpoIVbDzklkZPxMs_jN28AjqxTUhBAQGnyzYmik0JTIYZOFcrBCCF57jFkFv_NbaH6pF_WjfpYqS9J2neIq_peW_XdF8mt7LQdLeGJafc3RVOcH-pZrUOb2izM8Tmbs8Y26nIRNjNCZkWUluOgRdGNXD0RJ81bmmNFA7k5IGmYz_NJm8mJk-dJWuSYn6ksw3PyhTG95FXtRUR1hn_EG6f6hRVYGqFPvIgfWYUZ5q_BQjEp-rYGi3EYD-PspHX4LA-w7_YDjIKB6yQLJf5qhGPQxPEqAch7SqysDguxFXj02D1BSVtnA9ZFEfVFj3vHoBPaw8BjiggBo-e2RMbx1_sH8qv8U5kHu6LmaMxvD99wJPIqmz0uP9RO0O7brieSv1R8YAxLd7Uz_G_9DTivlB-LVWXC8I1OLLTRENLXk3e4OaUE9sh8-U1I-YHPtgBNg7t7K8vHpEk5yGQWYxzrUYsSW89Sg26DOWUjO1O_eQjz96VK47p2e7ULaQ61JDstl9mDVBT22D6HMxE5kAP3G6JFAzg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ex+vivo+toxicological+evaluation+of+experimental+anticancer+gold%28i%29+complexes+with+lansoprazole-type+ligands%E2%80%A0+%E2%80%A0Electronic+supplementary+information+%28ESI%29+available.+See+DOI%3A+10.1039%2Fc9tx00149b&rft.jtitle=Toxicology+research+%28Cambridge%29&rft.au=Estrada-Ortiz%2C+Natalia&rft.au=Lopez-Gonzales%2C+Elena&rft.au=Woods%2C+Ben&rft.au=St%C3%BCrup%2C+Stefan&rft.date=2019-09-20&rft.pub=Royal+Society+of+Chemistry&rft.issn=2045-452X&rft.eissn=2045-4538&rft.volume=8&rft.issue=6&rft.spage=885&rft.epage=895&rft_id=info:doi/10.1039%2Fc9tx00149b&rft_id=info%3Apmid%2F32190293&rft.externalDBID=PMC7067241
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-452X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-452X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-452X&client=summon